Ethics and Accessibility: The Dilemma of RISD-PLAM Pricing

This chapter examines the ethical dilemmas related to the pricing and availability of the drug RISD-PLAM for spinal muscular atrophy patients in India. It highlights the conflict between Roche and Natco Pharma over generic production, while providing insight into India's patent laws and the need for affordable healthcare.